Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care
Autors principals: Menzella, Francesco, Fontana, Matteo, Salvarani, Carlo, Massari, Marco, Ruggiero, Patrizia, Scelfo, Chiara, Barbieri, Chiara, Castagnetti, Claudia, Catellani, Chiara, Gibellini, Giorgia, Falco, Francesco, Ghidoni, Giulia, Livrieri, Francesco, Montanari, Gloria, Casalini, Eleonora, Piro, Roberto, Mancuso, Pamela, Ghidorsi, Luca, Facciolongo, Nicola
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523258/
https://ncbi.nlm.nih.gov/pubmed/32993751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03306-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars